Mayo Clinic is a member of the Gynecologic Oncology Group (GOG), a national organization whose members conduct research to find the best treatments for gynecologic cancers. In addition, the National Cancer Institute (NCI) has designated Mayo Clinic as a comprehensive cancer center. This designation, given to only a few cancer centers in the United States, identifies the Mayo Clinic Cancer Center as an innovative research facility providing high-quality care to patients.
The Women's Cancer Program at Mayo Clinic conducts cutting-edge, innovative research to improve treatment management options for women with breast and gynecologic cancers. This multidisciplinary program brings together researchers and clinicians to further the current understanding of women's cancers, provide compassionate care, and educate patients and their families about women's cancers. Researchers in gynecologic surgery, medical and radiation oncology, medical genetics, pathology and other specialties work together to give women with cancer the widest possible range of treatment options. As part of the Mayo Clinic Cancer Center, the Women's Cancer Program is poised to offer innovative new therapies available through clinical trials. The Women's Cancer Program also provides psychosocial support classes, a resource center, and educational programs for patients and their families.
See a list of publications by Mayo Clinic doctors on uterine cancer on PubMed, a service of the National Library of Medicine.
Research descriptions of individual investigators on www.mayo.edu: